1. Home
  2. MTN vs MIRM Comparison

MTN vs MIRM Comparison

Compare MTN & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vail Resorts Inc.

MTN

Vail Resorts Inc.

HOLD

Current Price

$134.16

Market Cap

4.8B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$77.57

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTN
MIRM
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.2B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
MTN
MIRM
Price
$134.16
$77.57
Analyst Decision
Hold
Strong Buy
Analyst Count
11
11
Target Price
$173.91
$92.45
AVG Volume (30 Days)
1.2M
844.6K
Earning Date
12-10-2025
11-04-2025
Dividend Yield
6.63%
N/A
EPS Growth
17.26
N/A
EPS
7.24
N/A
Revenue
$2,975,101,000.00
$471,794,000.00
Revenue This Year
$2.48
$53.78
Revenue Next Year
$3.36
$19.91
P/E Ratio
$18.50
N/A
Revenue Growth
3.06
53.66
52 Week Low
$129.41
$36.88
52 Week High
$187.71
$82.58

Technical Indicators

Market Signals
Indicator
MTN
MIRM
Relative Strength Index (RSI) 38.05 58.25
Support Level $140.00 $77.99
Resistance Level $140.92 $82.58
Average True Range (ATR) 5.18 3.33
MACD -2.08 0.71
Stochastic Oscillator 17.39 74.62

Price Performance

Historical Comparison
MTN
MIRM

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: